Adaptive deep brain stimulation for children with epilepsy
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial tests a new type of brain stimulation (adaptive deep brain stimulation) that adjusts in real time to stop seizures in children with Lennox-Gastaut syndrome. It's for children who haven't gotten enough help from medications and have frequent drop seizures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 5 and 14 years old.
- Diagnosed with Lennox-Gastaut syndrome (LGS), confirmed by specific EEG patterns and drop seizures for at least 6 months.
- Had at least 10 seizures in the past 4 weeks.
- Tried at least 2 different seizure medications that didn't work well.
- Currently taking at least one seizure medication at a stable dose for 4 weeks.
- Willing to keep the same medications and diet during the study, and track seizures daily.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a brain implant that delivers electrical stimulation during sleep to reduce seizures in people with Lennox-Gastaut syndrome. It aims to improve seizure control and sleep quality.
This study tracks how brain wave patterns change when children and young adults with Lennox-Gastaut Syndrome (a severe seizure disorder) take fenfluramine, a medication that helps reduce drop seizures. Researchers will use EEG (brain wave recordings) to understand how this treatment affects the brain.
This study compares two types of brain stimulation—deep brain stimulation (DBS) and vagus nerve stimulation (VNS)—to see which is better at reducing epileptic spasms in children and teens who have not responded to at least two seizure medicines. The goal is to find a treatment that can help control seizures when medications have not worked.
This trial tests whether deep brain stimulation of a small area in the brain can help reduce seizures that start in the motor part of the brain and do not respond to medication. It may be an option for people who cannot have surgery or whose surgery did not help enough.
This trial tests a way of slowly increasing the dose of a CBD medicine (called Epidiolex) in adults with a severe type of epilepsy called Lennox-Gastaut syndrome (LGS). The goal is to find the best, most comfortable dose that helps reduce seizures.
This trial tests a brain stimulation treatment for people whose seizures are not controlled by medication and involve movement. It uses two targets in the brain to try to reduce these seizures.
Hear when a new Lennox Gastaut Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.